{"id":"W4389221945","doi":"10.1182/blood-2023-182942","title":"Multicenter Study of Mantle Cell Lymphoma Outcomes Following First-Line Bendamustine-Rituximab and Second-Line Bruton's Tyrosine Kinase Inhibitor Therapy","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Bendamustine; Rituximab; Mantle cell lymphoma; Medicine; Internal medicine; Progression-free survival; Maintenance therapy; Ibrutinib; Secondary hyperparathyroidism; Population; Oncology; Surgery; Chemotherapy; Lymphoma; Chronic lymphocytic leukemia; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009179931,0.000453464,0.0006708452,0.0005325424,0.0002692493,0.0009360334,0.0009232739,0.0005791545,0.001894215],"category_scores_gemma":[0.01011796,0.0002644006,0.001591347,0.0007463323,0.000258594,0.0006049455,0.0007348718,0.0006604302,0.0003205567],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001566912,"about_ca_system_score_gemma":0.00126576,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004800406,"about_ca_topic_score_gemma":0.00319642,"domain_scores_codex":[0.9970315,0.001667602,0.0001786806,0.0006226108,0.0001998129,0.0002998853],"domain_scores_gemma":[0.9863359,0.003158126,0.007146573,0.0009729707,0.001021781,0.001364771],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01379029,0.000834895,0.9720838,0.00007855389,0.001844311,0.0001232286,0.0001277629,0.00442662,0.0004573828,0.0002407904,0.000919306,0.005072984],"study_design_scores_gemma":[0.002576637,0.008316947,0.9622046,0.00007824592,0.001541227,0.0002730918,0.0001964181,0.02149828,0.0005508731,0.0002670762,0.002450857,0.00004567693],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971596,0.0003183934,0.0002955931,0.00007476745,0.000008127141,0.00009316974,0.001662318,0.000009661036,0.0003783616],"genre_scores_gemma":[0.9972649,0.0000595745,0.0001572045,0.00003977049,0.00001112338,0.00009142046,0.002244449,0.000003314668,0.0001281698],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009179931,"threshold_uncertainty_score":0.0485487,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02099516674128999,"score_gpt":0.2729382086107077,"score_spread":0.2519430418694177,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}